Extracorporal Shock Wave Treatment to Improve Nerve Regeneration

  • End date
    Jun 25, 2021
  • participants needed
  • sponsor
    Ludwig Boltzmann Gesellschaft
Updated on 25 January 2021


This study evaluates the impact of extracorporeal shock wave treatment after microsurgical coaptation of finger nerves. Participants will be randomized into two treatment groups with different settings and a sham group. The participants will thereafter followed-up in a prospective, double-blind study design.


Extracorporeal shock wave treatment is CE certified in Austria, Europe and licensed for indications like achillodynia, epicondylitis, or tendinitis calcanea. The Orthogold 100 device by MTS Medical UG will be used for this study.

Defocused low-energy extracorporeal shock wave therapy (ESWT) has gained acceptance as a therapeutic tool in different medical settings. It has been shown, that shock waves stimulate of the metabolic activity of different cell type, including osteoblasts, tenocytes, endothelial cells and chondrocytes. Furthermore, it has proved effective in clinical applications relating to bone and wound healing and myocardial ischaemia. Until now, no studies have been performed regarding the effects of ESWT on regeneration of peripheral nerve injuries in humans.

Treatment SHAM, MTS Medical UG Orthogold 100
Clinical Study IdentifierNCT03147313
SponsorLudwig Boltzmann Gesellschaft
Last Modified on25 January 2021

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.


Yes No Not Sure

Inclusion Criteria

Is your age between 18 yrs and 60 yrs?
Gender: Male or Female
Do you have any of these conditions: Peripheral Nerve Injury or Peripheral Neuropathy?
Do you have any of these conditions: Peripheral Neuropathy or Peripheral Nerve Injury?
complete lossless transection of one or more digital nerves distal to the branching out of the commune median or ulnar nerves
direct, tension-free coaptation of the nerve stumps

Exclusion Criteria

segment loss of the nerve
tension after direct coaptation
diabetic neuropathy or other peripheral neuropathies
other disease with reduced sensibility of the fingers
injuries in the course of the nerve (plexus brachialis, median or ulnar nerve)
chronic inflammatory disease
rheumatoid arthritis
patients not able to give written consent
patients with an implantable cardiac defibrillator or pacemaker
patients which are sensitive to electromagnetic radiance
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.
Step 2 Get screened

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more
Step 3 Enroll in the clinical study

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more
Step 4 Get your study results

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer


user name

Annotated by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No made yet